5 Red-Hot Buy-Rated Stocks Priced Under $10 With Huge Upside

Quipt Home Medical

This is a space many feel has huge growth potential due to an aging population. Quipt Home Medical Corp. (NASDAQ: QIPT) provides in-home monitoring equipment and disease management services, including end-to-end respiratory solutions for patients, in the United States.

The company offers daily and ambulatory aides; power mobility equipment; BiPAP and CPAP machines, nebulizers, oxygen concentrators and ventilators; oxygen therapy; sleep apnea and PAP treatment equipment; and home ventilator equipment, as well as rented respiratory equipment. The company also offers management of various chronic disease states, focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions.

Benchmark started coverage recently with a $7.50 price target. The consensus target is even higher at $10.50, and the stock closed at $5.57 on Friday.

Zeta Global

This company is in a white-hot business silo and has massive upside potential. Zeta Global Holdings Corp. (NASDAQ: ZETA) operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.

The company’s Zeta Marketing Platform analyzes billions of structured and unstructured data points to predict consumer intent by leveraging sophisticated machine learning algorithms and the industry’s opted-in data set for omnichannel marketing. Its Consumer Data Platform ingests, analyzes and distills disparate data points to generate a single view of a consumer, encompassing identity, profile characteristics, behaviors and purchase intent.

Zeta also offers various types of product suites, such as opportunity explorer, consumer experiences, omnichannel acquisition, and identity and data management. In addition, the company provides demand side platform and website personalization services. Its TruLift offers analysis to uniquely quantify incremental budgets that provide continued return on investment.

Barclays resumed coverage recently with a $12 price target. The consensus target is $12.25. The stock was last seen on Friday at $8.18 per share.

These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with absolutely no track record or liquidity, and major Wall Street firms have research coverage.

Sponsored: Tips for Investing

A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.

Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.